Yan Luo1,a, Yiheng Han2,a, Ying Zhang3,a,
Baoying Chen1,a, Qian Zhao1, Wenying Bi1,
Jiatong Sui1, Hongbing Duan1, Fengcai Zou1,4,
Xiao Xiao1,4,* and Yi Wu1,4,*
1College
of Veterinary Medicine, Yunnan Agricultural University, Kunming
650201, China; 2Department of Geriatrics, Jiangsu
Province Hospital of Chinese Medicine, Affiliated Hospital of
Nanjing University of Chinese Medicine; 3College of
Veterinary Medicine, China Agricultural University, Beijing 100193,
Beijing City, China; 4The Yunnan Key Laboratory of
Veterinary Etiological Biology, College of Veterinary Medicine,
Yunnan Agricultural University, Kunming 650201, Yunnan Province,
China. aThese authors contributed equally to this
article.
Nonalcoholic
steatohepatitis (NASH) is characterized by liver steatosis, inflammation and
metabolic disorders, and current treatment options are limited. The total
flavonoids extracted from the pueraria flower (TFP) have been reported to have
antioxidant and hepatoprotective effects. However, the
effects
of TFP on NASH and its underlying mechanisms remain unclear. To gain more
insight into the
pharmaceutical value
of TFP for
treating NASH, the chemical composition of TFP was analyzed by
UPLC‒ESI‒MS/MS.
A NASH mouse model was established to evaluate the effects of TFP on liver and
fat indices, serum biochemical parameters, and liver histopathology. The
composition of the gut microbiota was analyzed by 16S rRNA sequencing, and the
metabolome of the liver was studied.
Thirty-five
flavonoids were identified as the main components. In NASH mice, TFP was able to
reduce liver and epididymal fat indices and decrease serum
triglyceride,
total cholesterol, low-density lipoprotein cholesterol, aspartate
aminotransferase, and alanine aminotransferase levels. Histological analysis
confirmed the reduction
in
lipid deposition and improvement
in
liver structure. Additionally, TFP helped restore microbial diversity, increase
the abundance of beneficial bacteria, and correct the metabolic functions
related to the gut microbiota. Metabolomic analysis indicated that TFP could
reverse the bile acid, fatty acid, and amino acid metabolic disorders caused by
NASH, reduce
the levels of
harmful metabolites, and restore
the levels of
beneficial metabolites. Collectively, our data reveal that TFP intervention
correlates with comprehensive amelioration of NASH-associated pathological
phenotypes, accompanied by restored intestinal microecology, corrected hepatic
metabolic disorders, and balanced lipid signaling protein expression. While
these multi-omic and biochemical observations establish correlative links
between TFP treatment and improved liver function, definitive causal molecular
cascades need further functional experimental verification along the gut-liver
axis.
To Cite This Article:
Luo Y, Han Y, Zhang Y, Chen B, Zhao Q, Bi W, Sui J, Duan H, Zou F, Xiao X and Wu
Y, 2026. Treatment and mechanism of
total flavonoids from pueraria flower on
nonalcoholic
steatohepatitis (NASH) mice.
Pak Vet J, 46(7): 1708-1721. http://dx.doi.org/10.29261/pakvetj/2026.164